XML 22 R10.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS

3 Months Ended

Jun. 30, 2017

NOTE 5 – RELATED PARTY TRANSACTIONS

Nemaura Pharma Limited (Pharma) and NDM Technologies Limited (NDM) are entities controlled by the Company’s majority shareholder, Dewan F.H. Chowdhury.

In accordance with the United States Securities and Exchange Commission (SEC) Staff Accounting Bulletin 55, these financial statements are intended to reflect all costs associated with the operations of DDL and TCL. Pharma has invoiced DDL and TCL for research and development services. In addition, certain operating expenses of DDL and TCL were incurred and paid by Pharma and NDM which have been invoiced to the Company. Certain costs incurred by Pharma and NDM are directly attributable to DDL and TCL and such costs were billed to the Company. Prior to the year ended March 31, 2016, other costs were shared between the organizations. In situations where the costs were shared, expense has been allocated between Pharma and NDM and DDL and TCL using a fixed percentage allocation and were billed to the Company. Management believes the allocation methodologies used are reasonable. DDL and TCL advanced Pharma certain amounts to cover a portion of the costs.

Following is a summary of activity between the Company and Pharma and NDM for the three months ended June 30, 2017 and 2016. These amounts are unsecured, interest free, and payable on demand.

	Three Months Ended June 30, 2017 (unaudited) ($)			Three Months Ended June 30, 2016 (unaudited) ($)
Balance due from (to) Pharma and NDM at beginning of period		(687,609	)		(494,145	)
Amounts invoiced by Pharma to DDL and TCL (1)		(95,617	)		(209,444	)
Amounts invoiced by DDL to Pharma		-			16,025
Foreign exchange differences		(29,003	)		41,667
Balance due to Pharma and NDM at end of the period		(812,229	)		(645,897	)

(1) These amounts are included primarily in research and development expenses charged to the Company by Pharma and NDM.

Subsequent to June 30, 2017, the Company made payments to Pharma on the outstanding balances at June 30, 2017 of $440,000.